Incyte Biosciences Canada today announced that Health Canada has granted a Notice of Compliance for OPZELURA® (ruxolitinib ...

Systemic JAK inhibitor therapy with tofacitinib was associated with the most favorable outcomes among patients with extensive vitiligo.

Every animal is special in its own way, but cat Gatsby boats one truly rare appearance! The four-legged friend suffers from a ...

( MENAFN - ACN NewsWire) China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area ...

SI Swimsuit legend Winnie Harlow had already made a name for herself before she graced the pages of the magazine in 2019. The ...

It's most common in children and adolescents. Vitiligo is an autoimmune condition that causes patches of the skin to lose color, resulting in white spots. This condition develops when the immune ...

The first speaker at this seminar was Dr. Nobuhiro Nouchi from the Nouchi Dermatology Clinic in Japan who discussed the successful treatment of vitiligo and alopecia areata with the Company’s XTRAC ® ...

To schedule a meeting with Edesa during the conferences, please contact conference organizers or the company directly at ... .

Report Ocean has published a new report on the Phototherapy Equipment Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...

If farmers are criticized for the pollution caused by stubble burning, why is there no similar outrage toward industrialists ...

A study of ruxolitinib cream in patients with lichen planus indicated that the topical JAK inhibitor is a promising potential ...